<DOC>
	<DOCNO>NCT00620737</DOCNO>
	<brief_summary>The purpose study evaluate safety profile treatment effect Isolagen TherapyTM placebo administer stable restrictive burn scar affect joint area .</brief_summary>
	<brief_title>Pilot Safety Efficacy Study Isolagen Therapy Treatment Restrictive Burn Scars</brief_title>
	<detailed_description />
	<criteria>Subject least 18 year age Subject `` stable '' restrictive burn scar joint area restricts range motion ( ROM ) affect joint great equal 20 % deep fascia ( i.e. , underlie structure include ligament , tendon , muscle , bone must contribute restriction ) Subject agree maintain current physical therapy regimen duration study Subject must able provide write informed consent comply study requirement Females childbearing potential must negative urine pregnancy test screen visit must agree use reliable mean birth control duration study Male subject must agree use reliable mean birth control duration study Subject healthy , nonscarred post auricular , abdomen , back neck hairline , low abdomen , upper arm , side upper leg , axillary region ( lateral thorax ) skin area suitable biopsy Subject normal CBC , thyroid function , renal function , liver function , blood glucose SMA 18 Screening The restrictive burn scar treat primarily classify keloid scar Surgical release scar treat within last 12 month Subjects skin biopsy collect Plans initiate new scar therapy study period Treatment investigational product procedure within 30 day prior study enrollment plan participate another clinical trial course study History active autoimmune disease organ transplantation Diagnosis cancer , include basal cell carcinoma , unless successfully treat remission minimum 6 month Known genetic disorder affect fibroblast collagen , achondroplasia , osteogenesis imperfecta , epidermolysis bullosa , ataxiatelangiectasia , Ehlers Danlos syndrome Active systemic infection show one following : symptom , fever and/or elevate white count ( subject present active systemic infection may enrol biopsied infection resolve ) Requires chronic antibiotic steroidal therapy Any condition consider Investigator contraindication biopsy injection Pregnant lactate woman woman try become pregnant study Subject disorder may prevent compliance , history chronic alcohol drug abuse , significant mental nervous disorder illness would , Investigator 's opinion , interfere study Presence disease condition would result impairment range motion extremity , e.g . rheumatoid arthritis stroke Subjects know allergy gentamycin amphotericin B , sensitivity material bovine origin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>